ALCHEMAB THERAPEUTICS
Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. The company is building their transformative engine to identify drug targets and develop a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Alchemab Therapeutics was established in 2019 by Uri Laserson and Jane Osbourn in London, England.
ALCHEMAB THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.alchemab.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
85.59 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Google Analytics 4 Nginx
Similar Organizations
Acesion Pharma
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Avea Life
Science-Based Longevity supplements formulated in Switzerland to help you be as young as you feel.
Calypso Biotech
Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Ucello Therapeutics
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Alchemab Therapeutics
Biomedical Catalyst Fund
Biomedical Catalyst Fund investment in Grant - Alchemab Therapeutics
RA Capital Management
RA Capital Management investment in Series A - Alchemab Therapeutics
Lightstone Ventures
Lightstone Ventures investment in Series A - Alchemab Therapeutics
DCVC
DCVC investment in Series A - Alchemab Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Series A - Alchemab Therapeutics
SV Health Investors
SV Health Investors investment in Series A - Alchemab Therapeutics
DHVC
DHVC investment in Series A - Alchemab Therapeutics
DCVC Bio
DCVC Bio investment in Seed Round - Alchemab Therapeutics
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Alchemab Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-26 | Alchemab Appoints Young T. Kwon as Chief Executive Officer |
| 2021-11-15 | Alchemab Therapeutics Appoints Young T. Kwon, PhD as Chief Financial and Operating Officer |
Official Site Inspections
http://www.alchemab.com Semrush global rank: 6.21 M Semrush visits lastest month: 1.09 K
- Host name: 139.254.197.35.bc.googleusercontent.com
- IP address: 35.197.254.139
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
More informations about "Alchemab Therapeutics"
Reverse engineering human nature | Alchemab Therapeutics
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with …See details»
News | Alchemab Therapeutics
Sep 12, 2024 Cambridge, UK, 06 June 2024 – Alchemab Therapeutics (Alchemab), an …See details»
Alchemab Therapeutics - Crunchbase Company Profile …
Additionally, Alchemab Therapeutics has successfully raised an $82 million funding round, providing significant financial resources to support its …See details»
Alchemab appoints Co-Founder Jane Osbourn as Chief Executive …
Sep 12, 2024 Alchemab Chair and Managing Partner at SV Health Investors, Kate Bingham, …See details»
Member profile: Alchemab Therapeutics | BIA - BioIndustry
Alchemab is building a broad pipeline of protective therapeutics for hard-to-treat diseases, with …See details»
Alchemab Therapeutics - MassBio
Jul 31, 2023 Alchemab is harnessing the naturally protective power of patient antibodies to …See details»
Alchemab Therapeutics - Funding, Financials, Valuation & Investors
Alchemab Therapeutics is developing protective antibodies designed to keep people free of …See details»
Alchemab Therapeutics Company Profile 2024: Valuation, Funding ...
Alchemab Therapeutics was founded in 2019. Where is Alchemab Therapeutics …See details»
Senior Leadership | Groups | Alchemab Therapeutics
Jenny Howell oversees project management at Alchemab and is responsible for managing our …See details»
Alchemab's new well-connected CEO will lead biotech on journey …
Jun 22, 2021 After overseeing the $2.5 billion acquisition of Ra Pharmaceuticals last year, …See details»
Alchemab Extends Partnership with Medicines Discovery Catapult …
Mar 7, 2022 Alchemab Therapeutics - a biotechnology company focused on the discovery …See details»
Alchemab Therapeutics— Cracking the secrets of protective
Sep 12, 2022 Alchemab’s approach focuses on so-called ‘resilient’ cohorts — people who are …See details»
Alchemab Therapeutics - Craft
Alchemab Therapeutics is a biotech company developing novel products for patients with …See details»
Alchemab and Medicines Discovery Catapult to develop landmark …
Mar 16, 2021 Alchemab is working in collaboration with Medicines Discovery Catapult, a not …See details»
Nature’s most effective search engine | Alchemab Therapeutics
Alchemab identifies these naturally occurring protective antibodies by mining the antibody …See details»
Alchemab raises £60M ($82M) in Series A financing to advance …
Apr 15, 2021 Alchemab Therapeutics, a biotech company developing novel products for …See details»
Join Our Team! | Alchemab Therapeutics
Careers. We are dedicated to the discovery and development of therapeutics to treat and cure …See details»
Alchemab to Collaborate With AstraZeneca to Use Alchemab’s …
May 5, 2021 Dr Jane Osbourn, CSO at Alchemab, commented: “Our collaboration with …See details»
Alchemab Announces Publication of AntiBERTa, an Antibody …
May 19, 2022 Alchemab’s novel approach learns from nature and naturally optimized …See details»